Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Redbiotec AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10641
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing products in the areas of CMV, HPV and influenza. Redbiotec also develops herpes vaccines. The company’s products find applications in the areas of cervical cancer induced by human papilloma virus; and influenza. It also provides customized solutions in biologics. The company operates through various pharmaceutical and biotech companies and universities. Redbiotec is headquartered in Schlieren, Switzerland.

Redbiotec AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Redbiotec AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec AG – Key Competitors 15
Redbiotec AG – Key Employees 16
Redbiotec AG – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Redbiotec AG, Pharmaceuticals & Healthcare, Key Facts 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Deals By Therapy Area, 2012 to YTD 2018 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec AG, Key Competitors 15
Redbiotec AG, Key Employees 16

List of Figures
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endo International plc:企業の戦略・SWOT・財務情報
    Endo International plc - Strategy, SWOT and Corporate Finance Report Summary Endo International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JSC KazMunaiGas Exploration Production:企業のM&A・事業提携・投資動向
    JSC KazMunaiGas Exploration Production - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC KazMunaiGas Exploration Production Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Ellex Medical Lasers Limited (ELX)-医療機器分野:企業M&A・提携分析
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Adocia SAS (ADOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Adocia SAS (Adocia) is a biotechnology company that discovers and develops therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. It offers novel insulin formulations for the treatment of diabetes and BioChaperone Lispro …
  • Cessna Aircraft Company:企業の戦略・SWOT・財務分析
    Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report Summary Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Duke Energy Corporation (DUK)-エネルギー分野:企業M&A・提携分析
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Topaz Energy and Marine Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Topaz Energy and Marine Ltd (Topaz), a subsidiary of Renaissance Services SAOG, is an oil and gas company that offers offshore support vessels and marine solutions. The company's services include platform supply, anchor handling, emergency recovery and response and crew transfer. It operates …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Valensa International LLC:企業の戦略・SWOT・財務分析
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Polymetal International Plc:企業のM&A・事業提携・投資動向
    Polymetal International Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Polymetal International Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Sibanye Gold Ltd:戦略・SWOT・企業財務分析
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • DCP Midstream LP (DCP):企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such a …
  • HDFC Bank Ltd:企業のM&A・事業提携・投資動向
    HDFC Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • KAZ Minerals PLC:企業のM&A・事業提携・投資動向
    KAZ Minerals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KAZ Minerals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆